Dr. Jeffrey Cohen

Beth Israel Medical CenterNew York, New York - 10003 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2008

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
December 2008 - December 2012
Epilepsy
Epilepsies, Partial
Eslicarbazepine Acetate



